Anish Vanraj Bafna
About Anish Vanraj Bafna
Data last updated:
Anish Vanraj Bafna is a Director at Mankind Pharma Limited (since 2026), Director at Healthium Medtech Limited (since 2018) and Individual Subscriber at Quality Needles Precision Medtech Private Limited (since 2025), and holds 1 more current directorship. The companies operate in Pharma, Healthcare and Internet. The 2 current companies with reported revenue have a combined latest revenue of ₹15,507 Cr; the largest is Mankind Pharma Limited at ₹14,636 Cr (FY 2026). Earlier, Anish Vanraj Bafna was a Director at Carenow Lifesciences Private Limited (2023–2026) and Managing Director at Baxter India Private Limited (2010–2014) and 3 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Mankind Pharma Limited L74899DL1991PLC044843 | Director | 10 Aug 2026 | 1991 | ₹14,636 Cr (FY 2026) | Active |
 Healthium Medtech Limited U03311KA1992PLC013831 | Director | 29 Nov 2018 | 1992 | ₹870 Cr (FY 2025) | Active |
 Quality Needles Precision Medtech Private Limited U46596KA2025PTC206970 | Individual Subscriber | 21 Aug 2025 | 2025 | Active | |
 Padup Ventures Services Llp AAH-3084 | Partner | 26 Jul 2024 | 2016 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Carenow Lifesciences Private Limited U20237TZ2023FTC029603 | Director | 09 Oct 2023 | 2023 | ₹21.05 Cr (FY 2025) | Active |
 Baxter India Private Limited U33112HR1996PTC038528 | Managing Director | 25 Jan 2010 | 1996 | ₹505 Cr (FY 2024) | Active |
 Paramount Surgimed Limited U74899DL1993PLC055981 | Additional Director | 22 Dec 2025 | 1993 | ₹123 Cr (FY 2025) | Active |
 Quality Needles Private Limited U74899KA1984PTC201717 | Additional Director | 20 Mar 2019 | 1984 | ₹331 Cr (FY 2025) | Active |
 Organisation Of Pharmaceutical Producers Of India U91120MH1965GAP013389 | Director | 26 Sep 2014 | 1965 | ₹15.58 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Anish Vanraj Bafna
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Anish Vanraj Bafna
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Anish Vanraj Bafna
Anish Vanraj Bafna currently holds 4 directorships: Mankind Pharma Limited (Director, since 10 Aug 2026, revenue ₹14,636 Cr (FY 2026)); Healthium Medtech Limited (Director, since 29 Nov 2018, revenue ₹870 Cr (FY 2025)); Quality Needles Precision Medtech Private Limited (Individual Subscriber, since 21 Aug 2025); Padup Ventures Services Llp (Partner, since 26 Jul 2024).
Anish Vanraj Bafna was first appointed on 25 Jan 2010 as Managing Director at Baxter India Private Limited. The most recent appointment on record is 10 Aug 2026 at Mankind Pharma Limited.
The 2 current companies of Anish Vanraj Bafna that report revenue have a combined latest revenue of ₹15,507 Cr: Mankind Pharma Limited ₹14,636 Cr (FY 2026); Healthium Medtech Limited ₹870 Cr (FY 2025).
Anish Vanraj Bafna held 5 earlier board appointments: Carenow Lifesciences Private Limited (Director, 09 Oct 2023 to 30 Jun 2026); Baxter India Private Limited (Managing Director, 25 Jan 2010 to 31 Dec 2014); Paramount Surgimed Limited (Additional Director, 22 Dec 2025 to 22 Dec 2025); Quality Needles Private Limited (Additional Director, 20 Mar 2019 to 11 Apr 2019); Organisation Of Pharmaceutical Producers Of India (Director, 26 Sep 2014 to 09 Jul 2015).
The current boards of Anish Vanraj Bafna's companies include Ashutosh Dhawan (Mankind Pharma Limited), Hitesh Kumar Jain (Mankind Pharma Limited), Rajeev Juneja (Mankind Pharma Limited), Ramesh Juneja (Mankind Pharma Limited), Satish Kumar Sharma (Mankind Pharma Limited), Sheetal Arora (Mankind Pharma Limited), among others.